Skip to Content

  • Search

View Additional Section Content

211 – A Phase II pilot investigation of the relationship of short term Depo-Provera (Medroxyprogesterone Acctate, NSC #26386) exposure to the morphologic, biochemical, and molecular changes in Primary Endometrioid Adenocarcinoma of the Uterine Corpus

Clinical Trial Categories

  • Corpus Uterus/Endometrial Cancer
Hanjani Institute for Gynecologic Oncology at 215-885-0220


  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details